{"url_path":"/sec/cik-0001839133/8-k/2026-06-03/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1839133/0001493152-26-027047-index.html","accession_number":"0001493152-26-027047","cik":"0001839133","ticker":null,"issuer_name":"IR-Med, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1839133/0001493152-26-027047-index.html","primary_entity_key":"0001839133","primary_entity_name":"IR-Med, Inc."},"word_count":128,"has_tables":true,"body_markdown":"** **\n\n**Item\n5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of\nCertain Officers.**\n\n \n\nOn\nMay 28, 2026, the Board approved the grant of (i) an aggregate of options to purchase 5,040,000 shares of Common Stock to Oded Bashan,\nChairman of the Company, (ii) an aggregate of options to purchase 3,236,519 shares of Common Stock to Aharon Klein, a Director\nof the Company and (iii) an aggregate of options to purchase 2,779,988 shares of Common Stock to Yaniv Cohen, a Director of the Company.\nEach of the options were fully vested at issuance, have a term of ten (10) years and have an exercise price of $0.001 per share. The\noptions were granted outside of the Company’s 2020 Incentive Stock Option Plan."}